Cargando…
The Role of Comorbidity in Mortality After Hip Fracture: A Nationwide Norwegian Study of 38,126 Women With Hip Fracture Matched to a General-Population Comparison Cohort
Hip fracture patients often have comorbid conditions. We investigated whether the combination of comorbidity and hip fracture could explain the previously observed excess mortality among hip fracture patients as compared with the general population. Using a population-based matched study design with...
Autores principales: | Lunde, Astrid, Tell, Grethe S, Pedersen, Alma B, Scheike, Thomas H, Apalset, Ellen M, Ehrenstein, Vera, Sørensen, Henrik T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357811/ https://www.ncbi.nlm.nih.gov/pubmed/30407488 http://dx.doi.org/10.1093/aje/kwy251 |
Ejemplares similares
-
Initiation of anti-osteoporotic drugs in high-risk female patients starting glucocorticoid treatment: a population study in Norway
por: Apalset, Ellen M., et al.
Publicado: (2020) -
Impact of Total Hip Replacements on the Incidence of Hip Fractures in Norway During 1999–2019. A Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) Study
por: Kjeldgaard, Helena Kames, et al.
Publicado: (2022) -
Contribution of an extensive medication-based comorbidity index (Rx-Risk) in explaining the excess mortality after hip fracture in older Norwegians: a NOREPOS cohort study
por: Holvik, Kristin, et al.
Publicado: (2022) -
Airflow limitation as a risk factor for low bone mineral density and hip fracture: The Hordaland Health Study (HUSK) – 10 years follow-up of a general population
por: Herland, Trine, et al.
Publicado: (2016) -
Cause-specific excess mortality after hip fracture: the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS)
por: Holvik, Kristin, et al.
Publicado: (2023)